Document is current
Any future updates will be listed below
-
Authors
Tao, Y. Allen
Sakai, Holt A. https://orcid.org/0000-0002-9338-1484
Jiang, Allen Y. https://orcid.org/0000-0002-9826-5976
Krasnow, Nicholas A. https://orcid.org/0000-0002-4131-1855
Vaganov, Vasilii S.
Shim, Brian
Barsdale, Zachary https://orcid.org/0000-0003-1196-8669
Pandey, Smriti https://orcid.org/0000-0001-5461-5690
Ahmed, Nouraiz
Na, Man https://orcid.org/0009-0002-8892-7881
Liao, Ting-Wei
Oye, Keyede
Cristian, Ana
Zhang, Emily https://orcid.org/0000-0002-9053-1336
Xu, Joy A. https://orcid.org/0009-0007-7648-4805
Bulcaen, Mattijs
Liu, David R. https://orcid.org/0000-0002-9943-7557
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (R01EB031172)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35GM118062)
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (RM1HG009490)
- License Information
-
More Information
Article History
Received: 25 November 2025
Accepted: 27 April 2026
First Online: 21 May 2026
Competing interests
: Y.A.T., H.A.S., A.Y.J., N.A.K. and D.R.L. have filed patent applications related to this work through the Broad Institute. S.P. is an employee of CRISPR Therapeutics. D.R.L. is a cofounder of Beam Therapeutics, Prime Medicine, Editas Medicine, Pairwise Plants and nChroma Bio, companies that use or deliver genome editing agents. All other authors have no competing interests.
